Status:
COMPLETED
Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
Lead Sponsor:
Pfizer
Conditions:
Hypertension
Eligibility:
All Genders
20-79 years
Phase:
PHASE3
Brief Summary
To investigate the safety and efficacy of the long-term use of amlodipine 10 mg in subjects who will be able to enter a long-term study after completing the parent study "A double-blind comparative st...
Detailed Description
NCT00415623 (protocol A0531085)
Eligibility Criteria
Inclusion
- Patients who had completed the preceding study A0531085, Phase III study, who the investigator judged to be able to further treatment of long term administration in terms of efficacy and safety
- Patients who had a treatment compliance rate of at least 80%
Exclusion
- The patient who met the discontinuation criteria in the preceding study A0531085
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT00443456
Start Date
May 1 2007
End Date
June 1 2008
Last Update
October 28 2009
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chikushino-shi, Fukuoka, Japan
2
Pfizer Investigational Site
Fukuoka, Fukuoka, Japan
3
Pfizer Investigational Site
Kitakyushu, Fukuoka, Japan
4
Pfizer Investigational Site
Yokohama, Kanagawa, Japan